SIRT6: therapeutic target for nonalcoholic fatty liver disease

Mengwei Zang, Bin Gao

Producción científica: Short surveyrevisión exhaustiva

3 Citas (Scopus)

Resumen

Recently, Hou et al. shifted the research focus from the function of nuclear sirtuin (SIRT)6 to that of cytoplasmic SIRT6, which deacetylates and activates long-chain acyl-CoA synthase 5 (ACSL5). Their findings provide mechanistic insight into the role of cytoplasmic SIRT6 in fatty acid oxidation, acting as a therapeutic target for combating nonalcoholic fatty liver disease (NAFLD).

Idioma originalEnglish (US)
Páginas (desde-hasta)801-803
Número de páginas3
PublicaciónTrends in Endocrinology and Metabolism
Volumen33
N.º12
DOI
EstadoPublished - dic 2022

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Huella

Profundice en los temas de investigación de 'SIRT6: therapeutic target for nonalcoholic fatty liver disease'. En conjunto forman una huella única.

Citar esto